Výsledky vyhľadávania
Stromová štruktúra MeSH - poly I-C
[d13.695.578.550.560.600]
- kyseliny nukleové, nukleotidy a nukleozidy [d13] +
- nukleotidy [d13.695] +
- polynukleotidy [d13.695.578] +
- polyribonukleotidy [d13.695.578.550] +
- poly C [d13.695.578.550.560] +
- poly I-C
[d13.695.578.550.560.600]
- poly I-C
- poly C [d13.695.578.550.560] +
- polyribonukleotidy [d13.695.578.550] +
- polynukleotidy [d13.695.578] +
- nukleotidy [d13.695] +
[d13.695.578.550.650.600]
- kyseliny nukleové, nukleotidy a nukleozidy [d13] +
- nukleotidy [d13.695] +
- polynukleotidy [d13.695.578] +
- polyribonukleotidy [d13.695.578.550] +
- poly I [d13.695.578.550.650] +
- poly I-C
[d13.695.578.550.650.600]
- poly I-C
- poly I [d13.695.578.550.650] +
- polyribonukleotidy [d13.695.578.550] +
- polynukleotidy [d13.695.578] +
- nukleotidy [d13.695] +
- kyseliny nukleové, nukleotidy a nukleozidy [d13] +
Stromová štruktúra MeSH - interferón beta
[d12.644.276.374.440.890.275]
[d12.776.467.374.440.890.275]
[d23.529.374.440.890.275]
Stromová štruktúra MeSH - oseltamivir
[d02.065.064.525]
- chemikálie organické [d02] +
- amidy [d02.065] +
- acetamidy [d02.065.064] +
- 2-acetylaminofluorén [d02.065.064.150] +
- alylisopropylacetamid [d02.065.064.189]
- benzénacetamidy [d02.065.064.294] +
- jódacetamid [d02.065.064.400]
- lakozamid [d02.065.064.416]
- levetiracetam [d02.065.064.432]
- linezolid [d02.065.064.463]
- oseltamivir
[d02.065.064.525]
- piracetam [d02.065.064.650]
- tioacetamid [d02.065.064.786]
- acetamidy [d02.065.064] +
- amidy [d02.065] +
[d02.455.426.392.368.367.379.500]
- chemikálie organické [d02] +
Stromová štruktúra MeSH - poly A-U
[d13.695.578.550.500.510]
- kyseliny nukleové, nukleotidy a nukleozidy [d13] +
- nukleotidy [d13.695] +
- polynukleotidy [d13.695.578] +
- polyribonukleotidy [d13.695.578.550] +
- poly A [d13.695.578.550.500] +
- poly A-U
[d13.695.578.550.500.510]
- poly A-U
- poly A [d13.695.578.550.500] +
- polyribonukleotidy [d13.695.578.550] +
- polynukleotidy [d13.695.578] +
- nukleotidy [d13.695] +
[d13.695.578.550.750.510]
- kyseliny nukleové, nukleotidy a nukleozidy [d13] +
- nukleotidy [d13.695] +
- polynukleotidy [d13.695.578] +
- polyribonukleotidy [d13.695.578.550] +
- poly U [d13.695.578.550.750] +
- poly A-U
[d13.695.578.550.750.510]
- poly A-U
- poly U [d13.695.578.550.750] +
- polyribonukleotidy [d13.695.578.550] +
- polynukleotidy [d13.695.578] +
- nukleotidy [d13.695] +
- kyseliny nukleové, nukleotidy a nukleozidy [d13] +
Stromová štruktúra MeSH - inhibítory reverznej transkriptázy
[d27.505.519.389.675.850]
- účinky chemické a spôsoby používania liekov a chemikálií [d27] +
- účinky farmakologické [d27.505] +
- mechanizmy farmakologického účinku, molekulárne [d27.505.519] +
- inhibítory enzýmov [d27.505.519.389] +
- inhibítory syntézy nukleových kyselín [d27.505.519.389.675] +
- inhibítory reverznej transkriptázy
[d27.505.519.389.675.850]
- inhibítory reverznej transkriptázy
- inhibítory syntézy nukleových kyselín [d27.505.519.389.675] +
- inhibítory enzýmov [d27.505.519.389] +
- mechanizmy farmakologického účinku, molekulárne [d27.505.519] +
- účinky farmakologické [d27.505] +
[d27.505.954.122.388.308]
- účinky chemické a spôsoby používania liekov a chemikálií [d27] +
- účinky farmakologické [d27.505] +
- použitie terapeutické [d27.505.954] +
- antiinfektíva [d27.505.954.122] +
- antivirotiká [d27.505.954.122.388] +
- antiretrovirotiká [d27.505.954.122.388.077] +
- inhibítory reverznej transkriptázy
[d27.505.954.122.388.308]
- inhibítory fúznych vírusových proteínov [d27.505.954.122.388.538] +
- inhibítory vírusovej proteázy [d27.505.954.122.388.769] +
- antivirotiká [d27.505.954.122.388] +
- antiinfektíva [d27.505.954.122] +
- použitie terapeutické [d27.505.954] +
- účinky farmakologické [d27.505] +
- účinky chemické a spôsoby používania liekov a chemikálií [d27] +